Avastin Hearing's Deadline For Written Submissions Is Indefinitely Delayed

Presiding Officer Karen Midthun postpones the submission deadline for written summaries of arguments by Genentech and CDER until one week after the formal hearing notice is issued, although it remains unclear when that will occur.

More from Archive

More from Pink Sheet